DEP domain containing 1B (DEPDC1B) exerts the tumor promoter in hepatocellular carcinoma through activating p53 signaling pathway via kinesin family member 23 (KIF23)

References

• Clark T, Maximin S, Meier J, et al. Hepatocellular carcinoma: review of epidemiology, screening, imaging diagnosis, response assessment, and treatment. Curr Probl Diagn Radiol. 2015 Nov-Dec;44(6):479–486.
   PubMed Web of Science ®Google Scholar
• Asafo-Agyei KO, Samant H. Hepatocellular Carcinoma. StatPearls (Treasure Island (FL): StatPearls Publishing). 2021, Aug 2021. Treasure Island (FL)2021. Bookshelf ID: NBK559177.
   Google Scholar
• Kole C, Charalampakis N, Tsakatikas S, et al. Immunotherapy for hepatocellular carcinoma: a 2021 update. Cancers (Basel). 2020 Oct 4;12(10):2859.
   PubMed Web of Science ®Google Scholar
• D’Souza S, Lau KC, Coffin CS, et al. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol. [2020 Oct 14];26(38):5759–5783.
   PubMed Web of Science ®Google Scholar
• Von Felden J, Garcia-Lezana T, Schulze K, et al. Liquid biopsy in the clinical management of hepatocellular carcinoma. Gut. 2020 Nov;69(11):2025–2034.
   PubMed Web of Science ®Google Scholar
• Shibata O, Kamimura K, Ko M, et al. Effect of Lenvatinib on a Hepatocellular Carcinoma with Fibroblast Growth Factor Receptor 4 Expression: a Case Report and Review of the Literature. Intern Med. [2021 Jun 1];60(11):1709–1715.
   PubMed Web of Science ®Google Scholar
• Pinto Marques H, Da Silva S G, De Martin E, et al. Emerging biomarkers in HCC patients: current status. Int J Surg. 2020;82S:70–76.
   PubMed Web of Science ®Google Scholar
• Figeac N, Pruller J, Hofer I, et al. DEPDC1B is a key regulator of myoblast proliferation in mouse and man. Cell Prolif. 2020 Jan;53(1):e12717.
   PubMed Web of Science ®Google Scholar
• Consonni SV, Maurice MM, Bos JL. DEP domains: structurally similar but functionally different. Nat Rev Mol Cell Biol. 2014 May;15(5):357–362.
   PubMed Web of Science ®Google Scholar
• Peck J, Douglas G, Wu CH, et al. Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships. FEBS Lett. [2002 Sep 25];528(1–3):27–34.
   PubMed Web of Science ®Google Scholar
• Su YF, Liang CY, Huang CY, et al. A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and enhanced Anchorage-independent growth in oral cancer cells that is mediated by Rac1 and ERK. J Biomed Sci. [2014 Aug 5];21(1):67.
   PubMed Web of Science ®Google Scholar
• Bai S, Chen T, Du T, et al. High levels of DEPDC1B predict shorter biochemical recurrence-free survival of patients with prostate cancer. Oncol Lett. 2017 Dec;14(6):6801–6808.
   PubMed Web of Science ®Google Scholar
• Gu Y, Li J, Guo D, et al. Identification of 13 key genes correlated with progression and prognosis in hepatocellular carcinoma by weighted gene co-expression network analysis. Front Genet. 2020;11:153.
   PubMed Web of Science ®Google Scholar
• Dou C, Xu Q, Liu J, et al. SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production. J Exp Clin Cancer Res. [2019 Feb 12];38(1):70.
   PubMed Web of Science ®Google Scholar
• Zhang S, Shi W, Hu W, et al. DEP Domain-Containing Protein 1B (DEPDC1B) promotes migration and invasion in pancreatic cancer through the Rac1/PAK1-LIMK1-Cofilin1 Signaling Pathway. Onco Targets Ther. 2020;13:1481–1496.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang Z, Gao L, et al. miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9. Onco Targets Ther. 2019;12:2149–2157.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego. Calif). 2001 Dec;25(4):402–408.
   Google Scholar
• Gui D, Cui Z, Zhang L, et al. Salidroside attenuates hypoxia-induced pulmonary arterial smooth muscle cell proliferation and apoptosis resistance by upregulating autophagy through the AMPK-mTOR-ULK1 pathway. BMC Pulm Med. [2017 Dec 12];17(1):191.
   PubMed Web of Science ®Google Scholar
• Liao J, Jin H, Li S, et al. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. [2019 Nov 6];38(1):454.
   PubMed Web of Science ®Google Scholar
• Ma A, Zhang R. Diosmetin inhibits cell proliferation, induces cell apoptosis and cell cycle arrest in liver cancer. Cancer Manag Res. 2020;12:3537–3546.
   PubMed Web of Science ®Google Scholar
• Lu J, Wang Z, Li S, et al. Quercetin Inhibits the Migration and Invasion of HCCLM3 Cells by Suppressing the Expression of p-Akt1, Matrix Metalloproteinase (MMP) MMP-2, and MMP-9. Med Sci Monit. 2018 Apr 27;24:2583–2589.
   PubMed Web of Science ®Google Scholar
• Huang J, Lu D, Xiang T, et al. MicroRNA-132-3p regulates cell proliferation, apoptosis, migration and invasion of liver cancer by targeting Sox4. Oncol Lett. 2020 Apr;19(4):3173–3180.
   PubMed Web of Science ®Google Scholar
• Liu LX, Lu JC, Zeng HY, et al. Mortalin stabilizes CD151-dependent tetraspanin-enriched microdomains and implicates in the progression of hepatocellular carcinoma. J Cancer. 2019;10(25):6199–6206.
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia (New York, NY). 2017 Aug;19(8):649–658.
   PubMed Web of Science ®Google Scholar
• Vasaikar SV, Straub P, Wang J, et al. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. [2018 Jan 4];46(D1):D956–d963.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. [2021 Jan 8];49(D1):D605–d612.
   PubMed Web of Science ®Google Scholar
• Liu G, Luo Q, Li H, et al. Increased oxidative phosphorylation is required for stemness maintenance in liver cancer stem cells from hepatocellular carcinoma cell line HCCLM3 cells. Int J Mol Sci. 2020 Jul 25;21(15):5276.
   PubMed Web of Science ®Google Scholar
• Gupta A, Shah K, Oza MJ, et al. Reactivation of p53 gene by MDM2 inhibitors: a novel therapy for cancer treatment. Biomed Pharmacother. 2019;109:484–492.
   PubMed Web of Science ®Google Scholar
• Tahmasebi Birgani M, Carloni V. Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy. Int J Mol Sci. 2017 Feb 14. 18(2):405.
   PubMed Web of Science ®Google Scholar
• Zhao H, Yu M, Sui L, et al. High expression of DEPDC1 promotes malignant phenotypes of breast cancer cells and predicts poor prognosis in patients with breast cancer. Front Oncol. 2019;9:262.
   PubMed Web of Science ®Google Scholar
• Lai CH, Xu K, Zhou J, et al. DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1. Cell Death Dis. [2020 Nov 17];11(11):986.
   PubMed Web of Science ®Google Scholar
• Dang XW, Pan Q, Lin ZH, et al. Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1. Aging (Albany NY). [2021 May 25];13(16):20094–20115.
   PubMedGoogle Scholar
• Cheng C, Wu X, Shen Y, et al. KIF14 and KIF23 promote cell proliferation and chemoresistance in HCC cells, and predict worse prognosis of patients with HCC. Cancer Manag Res. 2020;12:13241–13257.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Cheng Y, Jiang Y, et al. Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis. Int J Biol Sci. 2018;14(2):124–136.
   PubMed Web of Science ®Google Scholar
• Li TF, Zeng HJ, Shan Z, et al. Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer. Cancer Cell Int. 2020;20:123.
   PubMed Web of Science ®Google Scholar
• Kato T, Wada H, Patel P, et al. Overexpression of KIF23 predicts clinical outcome in primary lung cancer patients. Lung Cancer. 2016;92:53–61.
   PubMed Web of Science ®Google Scholar
• Chen GG, Merchant JL, Lai PB, et al. Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89. Am J Pathol. 2003 Jun;162(6):1823–1829.
   PubMed Web of Science ®Google Scholar
• Honda K, Sbisa E, Tullo A, et al. p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. Br J Cancer. 1998 Mar;77(5):776–782.
   PubMed Web of Science ®Google Scholar
• Chen J, Li GQ, Zhang L, et al. Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression. Cancer Lett. 2018 Jan 1;412:30–36.
   PubMed Web of Science ®Google Scholar